| 19 Aug 2009 |
|
Two top Egyptian young graduates selected to attend the global Novartis Biotechnology Leadership Camp "BioCamp" in USA
- Text size
Novartis Biotechnology Leadership Camp held for the second time in Egypt and the Middle East
BioCamp is a pioneering two-day seminar that brings the biotechnology sector closer to talented young university graduates. It has been held over the past four years in Switzerland, Japan, China and Taiwan. 25 talented young men and women from Egypt, Morocco and Palestine, selected after a rigorous application process, listened to lectures by international experts on the topic of Hepatitis B & C.
Dr. Sergio Abrignani, Director of the National Institute of Molecular Genetics in Milan, Italy delivered the opening address. Dr. Abrignani, who has made seminal contributions in the field of hepatitis C vaccines, gave a global view of the disease and state-of-the-art therapy. This was followed by a keynote address by Dr. Gamal Esmat, Head of the International Society for Liver Diseases and professor of Gastroenterology at Cairo University, who discussed hepatitis as a problem in Egypt.
Following the lectures, the BioCamp participants split into four groups to work on preparing a strategic plan to combat hepatitis. On the second day of the seminar, each group presented their plan to a panel of judges who then chose the best team and three top participants.
The two winners who will participate in the global BioCamp in the USA are Reem Olabi, who has a bachelor of science degree in pharmacy from Ain Shams University and is working towards a masters degree in biotechnology at the American University in Cairo and Maha Omar, a graduate of the Faculty of Medicine, Ain Shams University.
The participants also had a chance to explore career opportunities and network with local and global leaders in the biotechnology sector. For many, this was the first of many networking events that will help place them firmly on the first steps of their careers.
"Last year's winner of the international BioCamp was a young Egyptian doctor from Ain Shams University and Novartis is hoping to send another winner again to the international BioCamp this year," said Ali Toker, Novartis Egypt Country President.
Participation in BioCamp is highly selective and students who participated were chosen based on their academic excellence and professional focus.
"Participation in BioCamp is a very competitive process, but that is for good reason. We wanted to discover the hidden talent in the country, and support and sustain it through the international exposure and possible job opportunities that BioCamp provides. We also hope to help that talent flourish even further and attain its highest levels," he added.
For further information please contact:
Salah El Din Aloui
Assistant Media Relations Manager
Promoseven Weber Shandwick
Tel: +2 02 3047215 - 17
Fax: +2 02 3047213
Mob: +2 012 39 79 586
E-Mail: salah@promoseven.com
© Press Release 2009
Zawya is a distributor (and not a publisher) of content supplied by third parties and subscribers. Any opinions, advice, statements, services, offers, or other information or content expressed or made available by those third parties, including information providers, subscribers or other users of the Service, are those of the respective author(s) or distributor(s) and not of the Company. The Company neither endorses nor is responsible for the accuracy or reliability of any opinion, advice or statement made on the Service by anyone other than authorized Service employee spokespersons while acting in their official capacities. The Company is not responsible for any infringement of intellectual property rights or breach of any applicable law or regulation, including regulation in relation to financial services or the distribution of financial products, defamation, data protection, telecommunications (including regulations relating to excessive use, spamming or other abusive activities) or obscene, offensive or illegal content). Under no circumstances will the Company be liable for any loss or damage caused by a member's reliance on information obtained through the Service. It is the responsibility of member to evaluate the accuracy, completeness or usefulness of any information, opinion, advice or other content available through the Service. Please seek the advice of professionals, as appropriate, regarding the evaluation of any specific information, opinion, advice or other content.
Read the full Member Agreement
http://www.zawya.com/legal/NewsLetter.cfm?name=disclaimer
Post a Comment
1.1 Contain any material which is libelous or defamatory of any person, is obscene, offensive, hateful or inflammatory or causes damage to the reputation of any person or organisation.
1.2 Promote sexually explicit material, violence, discrimination based on race, sex, religion, nationality, disability, sexual orientation or age or any illegal activity.
1.3 Be made in breach of any legal duty owed to a third party, such as a contractual duty or a duty of confidence.
1.4 Be threatening, abuse or invade another's privacy, or cause annoyance, inconvenience or needless anxiety.
1.5 Be used to impersonate any person, to misrepresent your identity or affiliation with any person, or be likely to deceive any person.
1.6 Give the impression that they represent Zawya.
1.7 Advocate, promote or assist any unlawful act such as (by way of example only) copyright infringement or computer misuse.